A phase II dose‑escalation trial of perioperative desmopressin (1‑desamino‑8‑D‑arginine vasopressin) in breast cancer patients
Desmopressin (dDAVP) is a well-known peptide analog of the antidiuretic hormone vasopressin, used to prevent excessive bleeding during surgical procedures. dDAVP increases hemostatic mediators, such as the von Willebrand factor (vWF), recently considered a key element in resistance to metastasis. St...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/103080 https://springerplus.springeropen.com/articles/10.1186/s40064-015-1217-y |
| Aporte de: |
| id |
I19-R120-10915-103080 |
|---|---|
| record_format |
dspace |
| institution |
Universidad Nacional de La Plata |
| institution_str |
I-19 |
| repository_str |
R-120 |
| collection |
SEDICI (UNLP) |
| language |
Inglés |
| topic |
Medicina dDAVP Surgery Hemostasia von Willebrand factor Circulating tumor cells Breast cancer trial |
| spellingShingle |
Medicina dDAVP Surgery Hemostasia von Willebrand factor Circulating tumor cells Breast cancer trial Weinberg, Ruth S. Grecco, Marcelo O. Ferro, Gimena S. Seigelshifer, Debora J. Perroni, Nancy V. Terrier, Francisco Sánchez Luceros, Analía Maronna, Esteban Sánchez Marull, Ricardo Frahm, Isabel Guthmann, Marcelo D. Di Leo, Daniela Spitzer, Eduardo Ciccia, Graciela N. Garona, Juan Pifano, Marina Torbidoni, Ana V. Gémez, Daniel E. Ripoll, Giselle V. Gomez, Roberto E. Demarco, Ignacio A. Alonso, Daniel F. A phase II dose‑escalation trial of perioperative desmopressin (1‑desamino‑8‑D‑arginine vasopressin) in breast cancer patients |
| topic_facet |
Medicina dDAVP Surgery Hemostasia von Willebrand factor Circulating tumor cells Breast cancer trial |
| description |
Desmopressin (dDAVP) is a well-known peptide analog of the antidiuretic hormone vasopressin, used to prevent excessive bleeding during surgical procedures. dDAVP increases hemostatic mediators, such as the von Willebrand factor (vWF), recently considered a key element in resistance to metastasis. Studies in mouse models and veterinary trials in dogs with locally-advanced mammary tumors demonstrated that high doses of perioperative dDAVP inhibited lymph node and early blood-borne metastasis and significantly prolonged survival. We conducted a phase II dose-escalation trial in patients with breast cancer, administering a lyophilized formulation of dDAVP by intravenous infusion in saline, 30–60 min before and 24 h after surgical resection. Primary endpoints were safety and tolerability, as well as selection of the best dose for cancer surgery. Secondary endpoints included surgical bleeding, plasma levels of vWF, and circulating tumor cells (CTCs) as measured by quantitative PCR of cytokeratin-19 transcripts. Only 2 of a total of 20 patients experienced reversible adverse events, including hyponatremia (grade 4) and hypersensitivity reaction (grade 2). Reactions were adequately managed by slowing the infusion rate. A reduced intraoperative bleeding was noted with increasing doses of dDAVP. Treatment was associated with higher vWF plasma levels and a postoperative drop in CTC counts. At the highest dose level evaluated (2 μg/kg) dDAVP appeared safe when administered in two slow infusions of 1 μg/kg, before and after surgery. Clinical trials to establish the effectiveness of adjunctive perioperative dDAVP therapy are warranted. This trial is registered on www.clinicaltrials.gov (NCT01606072). |
| format |
Articulo Articulo |
| author |
Weinberg, Ruth S. Grecco, Marcelo O. Ferro, Gimena S. Seigelshifer, Debora J. Perroni, Nancy V. Terrier, Francisco Sánchez Luceros, Analía Maronna, Esteban Sánchez Marull, Ricardo Frahm, Isabel Guthmann, Marcelo D. Di Leo, Daniela Spitzer, Eduardo Ciccia, Graciela N. Garona, Juan Pifano, Marina Torbidoni, Ana V. Gémez, Daniel E. Ripoll, Giselle V. Gomez, Roberto E. Demarco, Ignacio A. Alonso, Daniel F. |
| author_facet |
Weinberg, Ruth S. Grecco, Marcelo O. Ferro, Gimena S. Seigelshifer, Debora J. Perroni, Nancy V. Terrier, Francisco Sánchez Luceros, Analía Maronna, Esteban Sánchez Marull, Ricardo Frahm, Isabel Guthmann, Marcelo D. Di Leo, Daniela Spitzer, Eduardo Ciccia, Graciela N. Garona, Juan Pifano, Marina Torbidoni, Ana V. Gémez, Daniel E. Ripoll, Giselle V. Gomez, Roberto E. Demarco, Ignacio A. Alonso, Daniel F. |
| author_sort |
Weinberg, Ruth S. |
| title |
A phase II dose‑escalation trial of perioperative desmopressin (1‑desamino‑8‑D‑arginine vasopressin) in breast cancer patients |
| title_short |
A phase II dose‑escalation trial of perioperative desmopressin (1‑desamino‑8‑D‑arginine vasopressin) in breast cancer patients |
| title_full |
A phase II dose‑escalation trial of perioperative desmopressin (1‑desamino‑8‑D‑arginine vasopressin) in breast cancer patients |
| title_fullStr |
A phase II dose‑escalation trial of perioperative desmopressin (1‑desamino‑8‑D‑arginine vasopressin) in breast cancer patients |
| title_full_unstemmed |
A phase II dose‑escalation trial of perioperative desmopressin (1‑desamino‑8‑D‑arginine vasopressin) in breast cancer patients |
| title_sort |
phase ii dose‑escalation trial of perioperative desmopressin (1‑desamino‑8‑d‑arginine vasopressin) in breast cancer patients |
| publishDate |
2015 |
| url |
http://sedici.unlp.edu.ar/handle/10915/103080 https://springerplus.springeropen.com/articles/10.1186/s40064-015-1217-y |
| work_keys_str_mv |
AT weinbergruths aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT greccomarceloo aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT ferrogimenas aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT seigelshiferdeboraj aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT perroninancyv aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT terrierfrancisco aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT sanchezlucerosanalia aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT maronnaesteban aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT sanchezmarullricardo aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT frahmisabel aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT guthmannmarcelod aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT dileodaniela aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT spitzereduardo aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT cicciagracielan aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT garonajuan aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT pifanomarina aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT torbidonianav aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT gemezdaniele aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT ripollgisellev aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT gomezrobertoe aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT demarcoignacioa aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT alonsodanielf aphaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT weinbergruths phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT greccomarceloo phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT ferrogimenas phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT seigelshiferdeboraj phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT perroninancyv phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT terrierfrancisco phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT sanchezlucerosanalia phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT maronnaesteban phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT sanchezmarullricardo phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT frahmisabel phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT guthmannmarcelod phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT dileodaniela phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT spitzereduardo phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT cicciagracielan phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT garonajuan phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT pifanomarina phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT torbidonianav phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT gemezdaniele phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT ripollgisellev phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT gomezrobertoe phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT demarcoignacioa phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients AT alonsodanielf phaseiidoseescalationtrialofperioperativedesmopressin1desamino8dargininevasopressininbreastcancerpatients |
| bdutipo_str |
Repositorios |
| _version_ |
1764820441466142720 |